DONATE

Emerging Leaders in Biomedicine Symposium

The second edition of the Emerging Leaders in Biomedicine Symposium will take place on September 26th, 2024 at the Vall d’Hebron Institute of Oncology. This exceptional event is a collaborative effort between: … Read more

Over-65s share their views on bioengineering research in IBEC and FECYT project

The IMAB project aims to involve the over-65s in learning about, understanding and expressing their opinions on the latest research in bioengineering for active ageing. The initiative has been carried out in collaboration with adult education centres, community centres, associations and university extension classes. The results will now be made available to the scientific community so that they can hear the public’s opinions and perspectives on these advances.

nanoBio&Med2024

The nanoBio&Med2024 International Conference (www.nanobiomedconf.com) will take place in-person in Barcelona (Nov 05-07, 2024). This event is going to present again the most recent international developments in the field of … Read more

Light-activated drugs against neuropathic pain

A team of researchers led by the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. These compounds, which show analgesic effects when activated by light, can inhibit nerve signals locally and on demand. Photopharmacological treatments offer precise action at the site of application, thus reducing systemic side effects.